Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insmed (INSM) Other Non Operating Income (2016 - 2026)

Insmed's Other Non Operating Income history spans 14 years, with the latest figure at -$736000.0 for Q1 2026.

  • Quarterly Other Non Operating Income fell 657.58% to -$736000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$283000.0 through Mar 2026, up 90.93% year-over-year, with the annual reading at -$236000.0 for FY2024, 173.75% down from the prior year.
  • Other Non Operating Income came in at -$736000.0 for Q1 2026, down from $453000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.4 million in Q1 2024 to a low of -$3.9 million in Q3 2024.
  • The 5-year median for Other Non Operating Income is -$378500.0 (2023), against an average of -$437833.3.
  • Year-over-year, Other Non Operating Income skyrocketed 268.4% in 2025 and then tumbled 657.58% in 2026.
  • Insmed's Other Non Operating Income stood at -$1.5 million in 2022, then skyrocketed by 141.55% to $634000.0 in 2023, then soared by 37.22% to $870000.0 in 2024, then plummeted by 47.93% to $453000.0 in 2025, then tumbled by 262.47% to -$736000.0 in 2026.
  • Per Business Quant, the three most recent readings for INSM's Other Non Operating Income are -$736000.0 (Q1 2026), $453000.0 (Q2 2025), and $132000.0 (Q1 2025).